Kolexia
Trone Jane-Chloé
Oncologie radiothérapie
Hôpital Nord CHU Saint-Étienne - Loire
Saint-Priest-en-Jarez, France
111 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Tumeurs du col de l'utérus Tumeurs du rectum Tumeurs de la prostate Récidive tumorale locale Carcinomes Carcinome épidermoïde Néphrocarcinome Tumeurs de la vulve

Industries

B3TSI
14 collaboration(s)
Dernière en 2023
IQVIA
4 collaboration(s)
Dernière en 2022
PASCALEO
4 collaboration(s)
Dernière en 2023
Ipsen
2 collaboration(s)
Dernière en 2023

Dernières activités

StrateGlio: Phase III Randomised Trial Evaluating Treatment Intensification With Temozolomide in Adults With a Glioblastoma
Essai Clinique (Centre Oscar-Lambret)   08 février 2024
GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
HOMEORAD: Phase III Trial Evaluating Radium Bromatum Homeopathic Treatment Efficacy on Radiodermatitis Prevention and Treatment for Breast Cancer Women
Essai Clinique (CHU Saint-Étienne)   04 mai 2023
Local treatment in the setting of de novo metastatic rectal cancer: reappraisal of prognostic factors.
Swiss medical weekly   15 décembre 2021
Focus on the expected quality of reporting in SBRT/radiosurgery prospective studies: how far have we come in 30 years?
The British journal of radiology   16 avril 2021
Assessment of non-inferiority with meta-analysis: example of hypofractionated radiation therapy in breast and prostate cancer.
Scientific reports   22 septembre 2020
Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
Radiation oncology (London, England)   08 juin 2020
Early detection of the existence or absence of the treatment effect: A cumulative meta-analysis.
Journal of clinical epidemiology   13 avril 2020
Stereotactic body radiotherapy: Passing fad or revolution?.
Bulletin du cancer   19 décembre 2019
Statistical controversies in clinical research: limitations of open-label studies assessing antiangiogenic therapies with regard to evaluation of vascular adverse drug events-a meta-analysis.
Annals of oncology : official journal of the European Society for Medical Oncology   25 novembre 2019